Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Complement dependent cytotoxicity

Known as: CDC 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Many therapeutic antibodies have been developed, and IgG antibodies have been extensively generated in various cell expression… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2013
Review
2013
Activation of the complement system by tumor cells was long believed to only benefit the host. Overexpression of complement… Expand
  • table 1
Is this relevant?
2012
2012
Abstract Complement dependent cytotoxicity (CDC) is an important mechanism of action for monoclonal antibodies (mAbs) used in the… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BackgroundSerum autoantibodies against the water channel aquaporin-4 (AQP4) are important diagnostic biomarkers and pathogenic… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The mechanism of cytotoxicity of alemtuzumab and rituximab in chronic lymphocytic leukemia (CLL) is not well understood. We… Expand
  • figure 2
  • figure 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The recent introduction of new technologies such as Luminex has provided alternative methods to the Complement Dependent… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The standard method to detect pretransplant antibodies has been the complement dependent cytotoxicity (CDC) test of donor… Expand
Is this relevant?
2004
2004
Metastases from renal cell carcinomas (RCC) are resistant to radiation and chemotherapy but are relatively immunogenic. We have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2001
2001
OBJECTIVE To study complement and cell mediated cytotoxicity by antiendothelial cell antibodies (AECA) in Takayasu's arteritis… Expand
Is this relevant?
1997
1997
BACKGROUND One reason for the failure of monoclonal antibody (mab) trials in most cancer patients might be the presence of… Expand
Is this relevant?